Wolfe Research Starts Zymeworks (ZYME) at Outperform
Wolfe Research analyst Kalpit Patel initiates coverage on Zymeworks (NASDAQ: ZYME) with a Outperform rating.
For an analyst ratings summary and ratings history on Zymeworks click here. For more ratings news on Zymeworks click here.

Shares of Zymeworks closed at $26.24 yesterday.

